Form 4: Oncology Institute CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Robert Ross Carter, CFO of Oncology Institute, sold 1,150 shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 19, 2025, Robert Ross Carter, the Chief Financial Officer of Oncology Institute, Inc. (TOI), sold 1,150 shares of Class A Common Stock.
- The sale was executed at a price of $0.889 per share.
- This transaction was done to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- Following the transaction, Carter directly owns 30,351 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
Sales to cover tax obligations are a routine part of equity compensation for executives. This transaction is not necessarily indicative of the CFO's sentiment about the company's future prospects.
Stakeholder Impact
- The sale of shares by the CFO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/19/2025 | Date of stock sale transaction |
| 03/20/2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, Oncology Institute, Robert Ross Carter, CFO, stock sale, tax withholding, restricted stock units, TOI
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.